Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancerEmmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
The Prostate|April 15, 2024
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical modelsSumer Jasmine, Adel Mandl, Timothy E G Krueger, et al.
Cancer Research|April 13, 2013
Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formationGrace M Wang, Hong Yuen Wong, Hiroyuki Konishi, et al.
European Urology Oncology|February 22, 2026
WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on DarolutamideBarak Talmor, Carole A Harris, Christopher Gianacas, et al.
Oncotarget|February 3, 2017
Detection fidelity of AR mutations in plasma derived cell-free DNAAlexa Goldstein, Patricia Valda Toro, Justin Lee, et al.
Cancer Research Communications|July 30, 2024
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II TrialChanning J Paller, Marianna L Zahurak, Adel Mandl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2017
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical TrialChanning J Paller, Xian C Zhou, Elisabeth I Heath, et al.
JCO Precision Oncology|May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate CancerSamantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancerRajendra Kumar, Sheila Jonnatan, David E Sanin, et al.
Cancer Research|October 14, 2021
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate CancerRajendra Kumar, Janet Mendonca, Olutosin Owoyemi, et al.
Pageof 23